Literature DB >> 386034

Biogenesis of mitochondria 51: biochemical characterization of a mitochondrial mutation in Saccharomyces cerevisiae affecting the mitochondrial ribosome by conferring resistance to aminoglycoside antibiotics.

T W Spithill, P Nagley, A W Linnane.   

Abstract

An examination of the effect of the aminoglycoside antibiotics paromomycin and neomycin on mitochondrial ribosome function in yeast has been made. Both antibiotics are potent inhibitors of protein synthesis in isolated mitochondria. With isolated mitochondrial ribosomes programmed with polyuridylic acid (poly U), the drugs are shown to inhibit polyphenylalanine synthesis at moderately high concentrations (above 100 microgram/ml). At lower concentrations (about 10 microgram/ml), paromomycin and neomycin cause a 2-3 fold stimulation in the extent of misreading of the UUU codons in poly U, over and above the significant level of misreading catalyzed by the ribosomes in the absence of drugs. Comparative studies have been made between a paromomycin sensitive strain D585-11C and a mutant strain 4810P carrying the par l-r mutation in mtDNA, which leads to high resistance to both paromomycin and neomycin in vivo. A high level of resistance to these antibiotics is observed in strain 4810P at the level of mitochondrial protein synthesis in vitro. Whilst the degree of resistance of isolated mitochondrial ribosomes from strain 4810P judged by the inhibition of polyphenylalanine synthesis by paromomycin and neomycin is not extensive, studies on misreading of the poly U message promoted by these drugs demonstrate convincingly the altered properties of mitochondrial ribosomes from the mutant strain 4810P. These ribosomes show resistance to the stimulation of misreading of the codon UUU brought about by paromomycin and neomycin in wild-type mitochondrial ribosomes. Although strain 4810P was originally isolated as being resistant to paromomycin, in all the in vitro amino acid incorporation systems tested here, the 4810P mitochondrial ribosomes show a higher degree of resistance to neomycin than to paromomycin. It is concluded that the parl-r mutation in strain 4810P affects a component of the mitochondrial ribosome, possibly by altering the 15S rRNA or a protein of the small ribosomal subunit. The further elucidation of the functions in the ribosomes that are modified by the parl-r mutation was hampered by the inability of current preparations of yeast mitochondrial ribosomes to translate efficiently natural messenger RNAs from the several sources tested.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 386034     DOI: 10.1007/bf00330306

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  36 in total

1.  Mitochondrial ribosome assembly in Neurospora. Preparation of mitochondrial ribosomal precursor particles, site of synthesis of mitochondrial ribosomal proteins and studies on the poky mutant.

Authors:  A M Lambowitz; N H Chua; D J Luck
Journal:  J Mol Biol       Date:  1976-11-05       Impact factor: 5.469

2.  Mutations of the mitochondrial DNA of Saccharomyces cerevisiae which affect the interaction between mitochondrial ribosomes and the inner mitochondrial membrane.

Authors:  T W Spithill; M K Trembath; H B Lukins; A W Linnane
Journal:  Mol Gen Genet       Date:  1978-08-17

Review 3.  Inhibitors of protein synthesis.

Authors:  D Vazquez
Journal:  FEBS Lett       Date:  1974-03-23       Impact factor: 4.124

4.  Mitochondrial antibiotic resistance in yeast: ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin.

Authors:  L A Grivell; P Netter; P Borst; P P Slonimski
Journal:  Biochim Biophys Acta       Date:  1973-06-23

5.  Biogenesis of mitochondria. 12. The effects of aminoglycoside antibiotics on the mitochondrial and cytoplasmic protein-synthesizing systems of Saccharomyces cerevisiae.

Authors:  P J Davey; J M Haslam; A W Linnane
Journal:  Arch Biochem Biophys       Date:  1970-01       Impact factor: 4.013

6.  The biogenesis of mitochondria, VI. Biochemical basis of the resistance of Saccharomyces cerevisiae toward antibiotics which specifically inhibit mitochondrial protein synthesis.

Authors:  A W Linnane; A J Lamb; C Christodoulou; H B Lukins
Journal:  Proc Natl Acad Sci U S A       Date:  1968-04       Impact factor: 11.205

7.  Alteration of ribosomal protein S17 by mutation linked to neamine resistance in Escherichia coli. I. General properties of neaA mutants.

Authors:  A Bollen; T Cabezón; M de Wilde; R Villarroel; A Herzog
Journal:  J Mol Biol       Date:  1975-12-25       Impact factor: 5.469

8.  Biogenesis of mitochondria 48: mikamycin resistance in Saccharomyces cerevisiae--a mitochondrial mutation conferring resistance to an antimycin A-like contaminant in mikamycin.

Authors:  D J Obbink; T W Spithill; R J Maxwell; A W Linnane
Journal:  Mol Gen Genet       Date:  1977-03-07

9.  Recombination among three mitochondrial genes in yeast (Saccharomyces cerevisiae).

Authors:  R A Kleese; R C Grotbeck; J R Snyder
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

10.  Biogenesis of mitchondria. Phospholipid synthesis in vitro by yeast mitochondrial and microsomal fractions.

Authors:  G S Cobon; P D Crowfoot; A W Linnane
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

View more
  3 in total

1.  Sls1p is a membrane-bound regulator of transcription-coupled processes involved in Saccharomyces cerevisiae mitochondrial gene expression.

Authors:  Anthony C Bryan; Matthew S Rodeheffer; Christopher M Wearn; Gerald S Shadel
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

2.  Mutations of the mitochondrial DNA of Saccharomyces cerevisiae which affect the interaction between mitochondrial ribosomes and the inner mitochondrial membrane.

Authors:  T W Spithill; M K Trembath; H B Lukins; A W Linnane
Journal:  Mol Gen Genet       Date:  1978-08-17

3.  Introduction and maintenance of prokaryotic DNA in Ustilago violacea.

Authors:  M H Perlin; A K Bej; O H Will; R J Jacob
Journal:  J Ind Microbiol       Date:  1990-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.